SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-16-000690
Filing Date
2016-02-26
Accepted
2016-02-26 09:54:52
Documents
1
Group Members
FOREST BASKETTKRISHNA S. KOLLURIM JAMES BARRETTNEA 12 GP LLCNEA PARTNERS 12 LIMITED PARTNERSHIPPATRICK J. KERINSPETER J. BARRISSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 PROTEOSTASIS THERAPEUTICS, INC. proteo-sch13d_17896.htm SC 13D 339570
  Complete submission text file 0001072613-16-000690.txt   341392
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 4102440115
New Enterprise Associates 12, Limited Partnership (Filed by) CIK: 0001383391 (see all company filings)

IRS No.: 204670653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Subject) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D | Act: 34 | File No.: 005-89403 | Film No.: 161458929
SIC: 2834 Pharmaceutical Preparations